COURTNEY FULLER: Open Payments
NPI 1801474887 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 6 payments from 6 companies in 2025. Trend: 2023 $243 · 2024 $335 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Amicus Therapeutics, Inc. | 1 | $21 |
| Sandoz Inc. | 1 | $19 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $18 |
| TerSera Therapeutics LLC | 1 | $17 |
Products named: ULTOMIRIS, VPRIV, JUBBONTI, PANHEMATIN, Quzyttir.
Industry payments across TX — which companies pay providers there.
